Gold Coast University Hospital is currently conducting a clinical study to evaluate an investigational vaccine that may provide protection against soft tissue infections caused by Staphylococcus aureus.

Patients may be eligible to participate in this study if they are 18 to 50 years old with a recent Staphylococcus aureus skin and soft tissue infection.

If you are interested in learning more about this study, or if you have a patient who may be interested in participating, please email GCHClinicalTrialServices@health.qld.gov.au